Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations
Open accessThe DOI matches its Crossref record.
Abstract
OBJECTIVES: Our objective was to identify evidence on the protection achieved by single-dose use of inactivated hepatitis A vaccines in order to evaluate the potential of a flexible booster administration in the form of a second dose. METHODS: A search was conducted for evidence on single-dose administration of inactivated hepatitis A vaccine and its potential impacts on long-term seropositivity rates. The main pharmaceutical vaccine manufacturer federations and the corresponding authors of manuscripts were approached for additional epidemiologic data. Correspondence was also sent to the Argentinean Ministry of Health. RESULTS: We identified 15 data sources reporting on protection achieved by a single dose of inactivated hepatitis A vaccine. The consistent finding was that the immune and memory response to the booster dose, or post-booster geometric mean titer, was independent of the time since initial vaccination. The impact of the booster on seroprotection was the same across sexes and age-groups. The longest time interval between initial and booster dose was 10.67 years, indicating that booster doses can be highly immunogenic for up to 10.67 years after primary vaccination. CONCLUSIONS: Protective anti-hepatitis A virus antibody levels after a single dose of inactivated hepatitis A vaccine can persist for almost 11 years and increase or reappear after booster vaccination. Further research on the vaccine doses needed to achieve long-term protection against hepatitis A infection is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lemon, S. M., Ott, J. J., Van Damme, P., & Shouval, D. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.034 · Cited by 336
Self-citationNelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., et al. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6905a1 · Cited by 264
Doshani, M., Weng, M., Moore, K. L., Romero, J. R., & Nelson, N. P. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6806a6 · Cited by 75
“Although recommended as a 2-dose series, evidence of protection for up to 11 years exists for 1 dose of single-antigen vaccine (10); clinical and outbreak response experience suggests that lifelong protection is possible after 1 dose.”
BackgroundSusceptibility to hepatitis A virus infection in the United States, 2007–2016.
Yin, S., Barker, L., Ly, K. N., Kilmer, G., Foster, M. A., Drobeniuc, J., & Jiles, R. B. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa298 · Cited by 46
Metadata
- Authors
- Ott, J. J., & Wiersma, S. T.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 17
- Issue
- 11
- Pages
- e939-e944
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W1967963754
- Cited by
- 71
- References
- 0
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. https://app.cochat.ai/papers/10.1016/j.ijid.2013.04.012
- The paper
- Ott, J. J., & Wiersma, S. T. (2013). Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2013.04.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.